Your browser is no longer supported. Please, upgrade your browser.
Settings
PODD Insulet Corporation daily Stock Chart
PODD [NASD]
Insulet Corporation
Index- P/E537.31 EPS (ttm)0.22 Insider Own0.70% Shs Outstand59.57M Perf Week-2.14%
Market Cap6.91B Forward P/E140.85 EPS next Y0.82 Insider Trans-24.42% Shs Float59.08M Perf Month6.90%
Income14.20M PEG21.49 EPS next Q0.03 Inst Own98.50% Short Float12.19% Perf Quarter19.95%
Sales599.80M P/S11.53 EPS this Y111.80% Inst Trans3.22% Short Ratio11.35 Perf Half Y57.97%
Book/sh3.77 P/B30.79 EPS next Y167.53% ROA1.60% Target Price106.88 Perf Year19.19%
Cash/sh5.31 P/C21.85 EPS next 5Y25.00% ROE7.00% 52W Range70.80 - 122.19 Perf YTD46.32%
Dividend- P/FCF- EPS past 5Y15.60% ROI3.20% 52W High-5.02% Beta1.11
Dividend %- Quick Ratio3.70 Sales past 5Y17.90% Gross Margin66.90% 52W Low63.93% ATR3.62
Employees1169 Current Ratio4.40 Sales Q/Q29.10% Oper. Margin5.80% RSI (14)61.56 Volatility2.89% 3.24%
OptionableYes Debt/Eq2.68 EPS Q/Q163.70% Profit Margin2.40% Rel Volume1.39 Prev Close117.72
ShortableYes LT Debt/Eq2.68 EarningsAug 01 AMC Payout0.00% Avg Volume634.12K Price116.06
Recom1.80 SMA201.97% SMA5012.97% SMA20026.58% Volume881,350 Change-1.41%
Jun-10-19Downgrade Northland Capital Outperform → Market Perform
May-06-19Upgrade BTIG Research Neutral → Buy $115
Apr-20-18Initiated Berenberg Buy $100
Feb-22-18Reiterated Barclays Overweight $85 → $90
Jan-08-18Upgrade Raymond James Mkt Perform → Outperform
Nov-03-17Upgrade Canaccord Genuity Hold → Buy $50 → $65
Sep-15-17Initiated Barclays Overweight $65
Jul-17-17Downgrade BTIG Research Buy → Neutral
May-25-17Resumed William Blair Outperform
May-22-17Resumed Piper Jaffray Overweight
Feb-28-17Reiterated Wedbush Outperform $48 → $50
Jan-06-17Upgrade Robert W. Baird Neutral → Outperform $39 → $47
Aug-04-16Reiterated Wedbush Outperform $44 → $48
Feb-26-16Upgrade The Benchmark Company Hold → Buy $30 → $40
Nov-06-15Reiterated Northland Capital Outperform $35 → $40
Nov-02-15Initiated Morgan Stanley Equal-Weight
Jul-08-15Initiated Robert W. Baird Neutral $34
May-04-15Upgrade Northland Capital Market Perform → Outperform $28 → $32
May-01-15Reiterated The Benchmark Company Buy $39 → $30
May-01-15Reiterated Oppenheimer Perform $33 → $31
Jun-25-19 10:49AM  Inside the low-key Boston design firm behind everything from sneakers to 'body on a chip' American City Business Journals
Jun-14-19 04:39PM  Did Hedge Funds Drop The Ball On Insulet Corporation (PODD) ? Insider Monkey
Jun-13-19 07:59AM  Insulet (PODD) Hits 52-Week High on Solid Growth Prospects Zacks
Jun-09-19 09:30PM  Insulets Omnipod® Horizon Hybrid Closed-Loop System Improves Glycemic Control in Patients as Young as Two Years Old with Type 1 Diabetes Business Wire
Jun-06-19 06:00AM  Insulet to Showcase its Recently-Launched Omnipod® DASH System and Present Seven Scientific Abstracts at the American Diabetes Association's 79th Scientific Sessions Business Wire
Jun-04-19 07:18AM  Why Diabetes Stock Insulet Soared 27.3% in May Motley Fool
Jun-01-19 09:31AM  Insulet (PODD) Up 27.8% Since Last Earnings Report: Can It Continue? Zacks
May-30-19 04:11PM  How IBD Called The Stock Market Correction Quickly And Where It May Go From Here Investor's Business Daily
May-29-19 04:01PM  Edited Transcript of PODD earnings conference call or presentation 2-May-19 8:30pm GMT Thomson Reuters StreetEvents
May-16-19 06:00AM  Insulet to Present at Upcoming Investor Conferences Business Wire
May-15-19 12:28PM  Insulet and West Pharma Proven Winners in Growing Wearable Devices Market GuruFocus.com
May-13-19 03:00AM  Insulet and Novocure Are Going Gangbusters Motley Fool
May-10-19 12:02PM  2 Winners and 2 Losers in the Med Tech Market This Quarter Motley Fool
May-04-19 03:00PM  Insulet Kicks Off 2019 With a Strong Quarter; Stock Soars 12% Motley Fool
May-03-19 12:11PM  Why Diabetes-Disruptor Insulet Is Skyrocketing 10% Today Motley Fool +12.30%
10:15AM  Should You Be Worried About Insulet Corporation's (NASDAQ:PODD) 1.6% Return On Equity? Simply Wall St.
09:14AM  Insulet Corp (PODD) Q1 2019 Earnings Call Transcript Motley Fool
08:02AM  Insulet (PODD) Beats Earnings and Revenue Estimates in Q1 Zacks
06:52AM  Medical device maker Insulet opens new Acton headquarters American City Business Journals
May-02-19 05:45PM  Insulet (PODD) Q1 Earnings and Revenues Beat Estimates Zacks
04:37PM  Insulet: 1Q Earnings Snapshot Associated Press
04:01PM  Insulet Reports First Quarter 2019 Revenue of $159.6 Million, an Increase of 29% Year-Over-Year Business Wire
06:00AM  Insulet Celebrates New Global Headquarters and U.S. Manufacturing Facility in Acton, MA Business Wire
May-01-19 12:01PM  Did David Stick His Neck Out Too Far With This 5-Stock Sampler? Motley Fool
Apr-29-19 10:10AM  Why the Earnings Surprise Streak Could Continue for Insulet (PODD) Zacks
08:01AM  20 High-Growth Stocks For The Next 20 Years Motley Fool
Apr-25-19 10:33AM  Insulet (PODD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Zacks
Apr-22-19 08:17PM  Is Insulet Corporation (PODD) A Good Stock To Buy? Insider Monkey
Apr-18-19 01:40PM  A Diabetes Treatment Revolution Could Bolster These Medtech Firms Investor's Business Daily
Apr-13-19 07:30PM  3 Top Diabetes Stocks to Watch in April Motley Fool
Apr-04-19 06:00AM  Insulet to Announce First Quarter 2019 Financial Results on May 2, 2019 Business Wire
Mar-27-19 09:30AM  Why Is Insulet (PODD) Up 5.1% Since Last Earnings Report? Zacks
Mar-16-19 06:00AM  3 Top Healthcare Stocks to Buy in March Motley Fool
Mar-03-19 11:32AM  Why Diabetes Stock Insulet Jumped 15.7% in February Motley Fool
Mar-01-19 06:22AM  Edited Transcript of PODD earnings conference call or presentation 25-Feb-19 9:30pm GMT Thomson Reuters StreetEvents
Feb-28-19 12:24PM  How Do Insulet Corporations (NASDAQ:PODD) Returns Compare To Its Industry? Simply Wall St.
Feb-27-19 06:55AM  Insulet (PODD) Beats Earnings and Revenue Estimates in Q4 Zacks
Feb-26-19 08:14AM  Insulet Posts Positive Earnings for the Second Consecutive Quarter Motley Fool
03:32AM  Insulet (PODD) Q4 2018 Earnings Conference Call Transcript Motley Fool
Feb-25-19 04:01PM  Insulet Reports Fourth Quarter 2018 Revenue of $164.9 Million, Up 26% Year-Over-Year, and Full Year 2018 Revenue of $563.8 Million, Up 22% Business Wire
02:30PM  Insulet Corporation to Host Earnings Call ACCESSWIRE
Feb-19-19 04:01PM  Insulet to Present at Upcoming Investor Conferences Business Wire
Feb-18-19 10:30AM  Insulet (PODD) Reports Next Week: Wall Street Expects Earnings Growth Zacks
Feb-17-19 02:00PM  3 Top Diabetes Stocks to Watch in February Motley Fool
Feb-15-19 06:16PM  Mariko Gordon's Top 5 New Buys for the 4th Quarter GuruFocus.com
Feb-07-19 08:10AM  Market Trends Toward New Normal in IHS Markit, KB Home, Insulet, Booking, Diebold Nixdorf, and Seritage Growth Properties Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Jan-28-19 04:01PM  Insulet Appoints Corinne Nevinny to Board of Directors Business Wire
Jan-25-19 08:30AM  Insulet to Announce Fourth Quarter and Full Year 2018 Financial Results on February 25, 2019 Business Wire
08:00AM  Today's Research Reports on Trending Tickers: Tandem Diabetes Care and Insulet Corporation ACCESSWIRE
Jan-23-19 09:01AM  3 Top Mid-Cap Stocks to Buy Right Now Motley Fool
Jan-08-19 04:58PM  Here's What Caused Tandem Diabetes Stock to Gain a Jaw-Dropping 1,509% in 2018 Motley Fool
Jan-07-19 07:00AM  Insulet Appoints Wayde McMillan Chief Financial Officer Business Wire
Jan-02-19 02:40PM  Here's Why Tandem Diabetes Care Is Dropping Today Motley Fool -7.43%
Dec-25-18 11:10AM  Are Insiders Selling Insulet Corporation (NASDAQ:PODD) Stock? Simply Wall St.
Dec-18-18 04:01PM  Insulet to Present at the 37th Annual J.P. Morgan Healthcare Conference Business Wire
Dec-14-18 12:43AM  Here is What Hedge Funds Think About Insulet Corporation (PODD) Insider Monkey
Dec-13-18 03:08PM  Facing headwinds, medtech sector won't be left to its own devices American City Business Journals
Dec-10-18 09:01AM  Insulet Gains on Omnipod Reimbursement Update, Rivalry Stiff Zacks
Dec-01-18 05:48PM  Insulet: Sugar or Spice? GuruFocus.com
Nov-30-18 07:00AM  Is It Time to Buy These Beaten-Up Bargains in Healthcare? Motley Fool
Nov-29-18 02:08PM  Is It Time to Buy Insulet? Motley Fool
08:45AM  Consolidated Research: 2018 Summary Expectations for Insulet, Yum China, Triton International, Tetra Technologies, Motorola Solutions, and Spotify Technology SA Fundamental Analysis, Key Performance Indications GlobeNewswire
Nov-23-18 10:11AM  What's in Store for GW Pharma (GWPH) This Earnings Season? Zacks
Nov-22-18 08:28AM  Insulet's (PODD) Omnipod DASH System Now ISO 27001 Certified Zacks
Nov-21-18 01:34PM  Here's Why Tandem Diabetes Care Is Jumping 16% Today Motley Fool
Nov-20-18 04:01PM  Insulets Omnipod DASH Insulin Management System Receives ISO 27001 Certification for Information Security Business Wire
Nov-19-18 04:01PM  Insulet to Present at Upcoming Investor Conferences Business Wire -7.16%
Nov-08-18 01:37PM  Edited Transcript of PODD earnings conference call or presentation 1-Nov-18 8:30pm GMT Thomson Reuters StreetEvents
Nov-07-18 04:01PM  Insulet Collaborates with Samsung to Deliver Galaxy Smartphone-Controlled Insulin Pump Delivery System Business Wire
12:40PM  Vanguard Health Care Fund Buys 4 Stocks in 3rd Quarter GuruFocus.com
Nov-06-18 11:59AM  TUV Rheinland OpenSky helps insulin pump by Insulet achieve cybersecurity certification by DTSec GlobeNewswire
Nov-05-18 06:42PM  How Insulet Helps People With Diabetes Live Longer and Happier Lives Bloomberg -5.34%
06:00AM  Insulet Raises Awareness for National Diabetes Awareness Month Business Wire
Nov-04-18 12:50PM  Insulet Achieves Quarterly Profitability for the First Time Motley Fool
Nov-02-18 10:55AM  Insulet (PODD) Beats Earnings and Revenue Estimates in Q3 Zacks
Nov-01-18 09:51PM  Insulet Corporation (PODD) Q3 2018 Earnings Conference Call Transcript Motley Fool
05:15PM  Insulet (PODD) Q3 Earnings and Revenues Top Estimates Zacks
04:07PM  Insulet: 3Q Earnings Snapshot Associated Press
04:01PM  Insulet Reports Third Quarter 2018 Revenue of $151.1 Million, Up 24% Year-Over-Year, and Gross Margin Over 67%, Up 700 Basis Points Business Wire
Oct-29-18 01:18PM  1 Extraordinary Investor, Plus a 5-Stock Sampler Annual Check-In Motley Fool
Oct-19-18 07:35AM  Analysis: Positioning to Benefit within Penumbra, Aetna, Littelfuse, IHS Markit, Credit Acceptance, and Insulet Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Oct-04-18 11:39AM  Europe Okays Use of Insulet's (PODD) Omnipod With Fiasp Zacks
Oct-02-18 12:01AM  Omnipod® Insulin Management System Now Available for Use in Europe with Fiasp® Fast-Acting Insulin Business Wire
Sep-27-18 11:33AM  Investing in Diabetes Stocks: A Beginner's Guide Motley Fool
Sep-24-18 06:00AM  Insulet to Announce Third Quarter 2018 Financial Results on November 1, 2018 Business Wire
Sep-19-18 09:55AM  Insulet Advances on Omnipod Reimbursement Update, Runs Risks Zacks
Sep-11-18 08:25AM  The Daily Biotech Pulse: Advaxis Posts Narrower Loss, Endocyte Announces $175M Offering, Leadership Transition At Insulet Benzinga
Sep-10-18 09:52PM  Insulet names its female president as next CEO American City Business Journals
04:01PM  Insulet Announces Shacey Petrovic, President and COO, Promoted to CEO, Effective January 1, 2019; Patrick Sullivan Will Retire as Chairman and CEO at the End of 2018 Business Wire
Sep-06-18 09:00AM  3 Growth Stocks for Forward-Looking Investors Motley Fool
Aug-28-18 06:00AM  Insulet to Present at Upcoming Investor Conferences Business Wire
Aug-17-18 07:28AM  Zacks.com featured highlights include: Entercom, Insulet, ESCO and Tristate Zacks
Aug-16-18 09:30AM  4 Top Stocks With the Power of Earnings Acceleration Zacks
06:00AM  Insulet to Showcase Its Omnipod DASH Insulin Management System at the American Association of Diabetes Educators Annual Conference Business Wire
Aug-15-18 05:40AM  Edited Transcript of PODD earnings conference call or presentation 2-Aug-18 8:30pm GMT Thomson Reuters StreetEvents
Aug-07-18 08:50AM  Insulet (PODD) Q2 Loss Narrower Than Expected, Revenues Lag Zacks
Aug-03-18 09:00AM  Insulet Achieves Operating Profitability, but Pares Back 2018 Revenue Guidance Motley Fool
Aug-02-18 05:15PM  Insulet (PODD) Reports Q2 Loss, Lags Revenue Estimates Zacks
04:09PM  Insulet: 2Q Earnings Snapshot Associated Press
04:01PM  Insulet Reports Second Quarter 2018 Revenue of $124.3 Million, Up 13% Year-Over-Year, and Gross Margin of 66%, Up 710 Basis Points Business Wire
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company offers Omnipod System, which consists of self-adhesive disposable tubeless Omnipod device (the pod) that delivers insulin into the body; and Personal Diabetes Manager, a handheld wireless device, which programs the Pod. It sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, Israel, and internationally. Insulet Corporation was founded in 2000 and is headquartered in Acton, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Spears Michael PSVP, RA and ComplianceJun 13Option Exercise29.262,00058,52027,275Jun 14 04:05 PM
Petrovic ShaceyPresident and CEOJun 05Sale113.00895101,13595,559Jun 05 05:21 PM
CRAWFORD SALLYDirectorMay 31Option Exercise28.9828,347821,38656,816Jun 03 05:35 PM
CRAWFORD SALLYDirectorMay 31Sale108.6028,3473,078,48428,469Jun 03 05:35 PM
Lemoine David ADirectorMay 16Option Exercise26.008,752227,55217,900May 17 04:07 PM
Lemoine David ADirectorMay 16Sale106.928,752935,7579,148May 17 04:07 PM
Lemoine David ADirectorMay 15Sale102.4987489,5769,148May 17 04:07 PM
Alpuche CharlesEVP & Chief Operating OfficerMay 15Sale104.783,900408,65239,244May 17 04:05 PM
Colleran DavidSVP, Secretary and GCApr 02Option Exercise30.987,395229,09737,828Apr 04 04:02 PM
Colleran DavidSVP, Secretary and GCApr 02Sale94.897,395701,71230,433Apr 04 04:02 PM
Fallon John A.DirectorMar 20Option Exercise21.355,000106,75016,743Mar 22 04:16 PM
Fallon John A.DirectorMar 20Sale100.005,000500,00011,743Mar 22 04:16 PM
Fallon John A.DirectorMar 12Option Exercise21.355,000106,75016,743Mar 14 05:06 PM
Abdel-Malek AimanEVP & Chief Technology OfficerMar 12Option Exercise37.0927,3491,014,38151,341Mar 14 05:07 PM
Abdel-Malek AimanEVP & Chief Technology OfficerMar 12Sale94.0327,3492,571,61323,992Mar 14 05:07 PM
Fallon John A.DirectorMar 12Sale95.005,000475,00011,743Mar 14 05:06 PM
Fallon John A.DirectorMar 06Option Exercise21.3510,000213,50021,743Mar 08 04:06 PM
Petrovic ShaceyPresident and CEOMar 06Sale92.641,06698,75496,454Mar 08 04:14 PM
Fallon John A.DirectorMar 06Sale92.6410,000926,40011,743Mar 08 04:06 PM
Colleran DavidSVP, Secretary and GCMar 01Option Exercise35.5420,975745,54451,408Mar 05 07:15 PM
Abdel-Malek AimanEVP & Chief Technology OfficerMar 01Sale95.221,608153,11923,992Mar 05 07:17 PM
Colleran DavidSVP, Secretary and GCMar 01Sale94.6520,9751,985,35930,433Mar 05 07:15 PM
Lemoine David ADirectorMar 01Sale94.2956152,89610,022Mar 05 07:06 PM
Levitz Michael LSVP and CFOFeb 27Sale92.011,350124,21456,651Feb 28 08:44 PM
Colleran DavidSVP, Secretary and GCFeb 05Option Exercise29.266,834199,96340,967Feb 06 04:34 PM
Colleran DavidSVP, Secretary and GCFeb 05Sale80.726,834551,64034,133Feb 06 04:34 PM
Colleran DavidSVP, Secretary and GCJan 31Option Exercise29.264,826141,20938,959Feb 01 05:29 PM
Colleran DavidSVP, Secretary and GCJan 31Sale80.004,826386,08034,133Feb 01 05:29 PM
Petrovic ShaceyPresident and COODec 06Option Exercise29.266,834199,96393,033Dec 10 05:48 PM
Colleran DavidSVP, Secretary and GCNov 14Option Exercise41.616,113254,36440,155Nov 15 04:24 PM
Colleran DavidSVP, Secretary and GCNov 14Sale80.416,113491,54634,042Nov 15 04:24 PM
Abdel-Malek AimanEVP & Chief Technology OfficerNov 14Sale80.4160248,40725,551Nov 15 04:02 PM
Petrovic ShaceyPresident and COONov 01Sale86.911,13498,55686,199Nov 05 04:34 PM
Abdel-Malek AimanEVP & Chief Technology OfficerOct 15Sale88.5860253,32526,153Oct 16 05:13 PM
Abdel-Malek AimanEVP & Chief Technology OfficerSep 14Sale107.9960265,01026,755Sep 18 05:18 PM
Petrovic ShaceyPresident and COOSep 04Sale104.26960100,09087,333Sep 05 06:14 PM
Spears Michael PSVP, QA and RAAug 14Sale86.085,043434,11327,304Aug 15 05:37 PM
Abdel-Malek AimanEVP & Chief Technology OfficerAug 14Sale86.6060252,13327,357Aug 15 05:26 PM
Abdel-Malek AimanEVP & Chief Technology OfficerJun 28Option Exercise31.2081125,30328,251Jun 29 04:07 PM